The Enterprise Value as of December 2025 (TTM) for Biodexa Pharmaceuticals Plc (BDRX) is -1172051.23

According to Biodexa Pharmaceuticals Plc’s latest financial reports and current stock price. The company's current Enterprise Value is -1172051.23. This represents a change of -147.19% compared to the average of 2.48M of the last 4 quarters.

Biodexa Pharmaceuticals Plc (BDRX) Historical Enterprise Value (quarterly & annually)

How has BDRX Enterprise Value performed in the past?

The mean historical Enterprise Value of Biodexa Pharmaceuticals Plc over the last ten years is 882.81K. The current -1172051.23 Enterprise Value has changed -13376.42% with respect to the historical average. Over the past ten years (40 quarters), BDRX's Enterprise Value was at its highest in in the December 2013 quarter at 28.43M. The Enterprise Value was at its lowest in in the June 2019 quarter at -7191138.65.

Biodexa Pharmaceuticals Plc (BDRX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Biodexa Pharmaceuticals Plc Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Biodexa Pharmaceuticals Plc (BDRX) Average Enterprise Value

How has BDRX Enterprise Value performed in the past?

The current Enterprise Value of Biodexa Pharmaceuticals Plc (BDRX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Biodexa Pharmaceuticals Plc (BDRX) Enterprise Value vs. Peers

How is BDRX’s Enterprise Value compared to its peers?

Biodexa Pharmaceuticals Plc’s Enterprise Value is greater than InMed Pharmaceuticals Inc. (-7952583.00), less than Genprex, Inc. (4.36M), less than GRI Bio, Inc. (356.75K), less than Jaguar Health, Inc. (30.76M), less than Estrella Immunopharma, Inc. (71.57M), less than Galmed Pharmaceuticals Ltd. (1.23M), greater than CNS Pharmaceuticals, Inc. (-6092778.00), greater than BioVie Inc. (-12510670.00), less than Kazia Therapeutics Limited (29.70M), less than Can-Fite BioPharma Ltd. (9.48M),

Build a custom stock screener for Biodexa Pharmaceuticals Plc (BDRX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Biodexa Pharmaceuticals Plc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Biodexa Pharmaceuticals Plc (BDRX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Biodexa Pharmaceuticals Plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.